Ironwood Pharmaceuticals, Inc. - Class A
IRWD Real Time Price USDRecent trades of IRWD by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by IRWD's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Stable formulations of linaclotide Jul. 07, 2020
-
Patent Title: Stable formulations of linaclotide Jun. 09, 2020
-
Patent Title: Sgc stimulators Jan. 29, 2019
-
Patent Title: Sgc stimulators Jan. 22, 2019
-
Patent Title: Sgc stimulators Aug. 14, 2018
-
Patent Title: Imidazotriazinone compounds May. 15, 2018
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Dec. 12, 2017
-
Patent Title: Imidazotriazinone compounds Aug. 08, 2017
-
Patent Title: Treatments for gastrointestinal disorders Jul. 18, 2017
-
Patent Title: Faah inhibitors May. 23, 2017
-
Patent Title: Treatments for gastrointestinal disorders May. 16, 2017
-
Patent Title: Treatments for gastrointestinal disorders Apr. 11, 2017
-
Patent Title: Sgc stimulators Mar. 07, 2017
-
Patent Title: Imidazotriazinone compounds Jan. 10, 2017
-
Patent Title: Treatments for gastrointestinal disorders Dec. 27, 2016
-
Patent Title: Sgc stimulators Nov. 08, 2016
-
Patent Title: Sgc stimulators Nov. 01, 2016
-
Patent Title: Sgc stimulators Apr. 12, 2016
-
Patent Title: Treatments for gastrointestinal disorders Apr. 05, 2016
-
Patent Title: Compositions comprising bile acid sequestrants for treating esophageal disorders Dec. 08, 2015
-
Patent Title: 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulators Sep. 22, 2015
-
Patent Title: Sgc stimulators Jun. 23, 2015
-
Patent Title: Nonoate derivatives and uses thereof May. 05, 2015
-
Patent Title: Treatments of gastrointestinal disorders Feb. 03, 2015
-
Patent Title: Indole compounds Nov. 11, 2014
-
Patent Title: Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration Aug. 12, 2014
-
Patent Title: Methods and compositions for the treatment of heart failure and other disorders Jul. 15, 2014
-
Patent Title: Formulations comprising linaclotide Jun. 10, 2014
-
Patent Title: Sgc stimulators Jun. 10, 2014
-
Patent Title: Treatments for gastrointestinal disorders May. 27, 2014
-
Patent Title: Crth2 modulators Mar. 18, 2014
-
Patent Title: Treatments for gastrointestinal disorders Aug. 13, 2013
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Feb. 07, 2012
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Jan. 24, 2012
-
Patent Title: Compounds and methods for the treatment of asthma Jan. 03, 2012
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Dec. 20, 2011
-
Patent Title: Useful indole compounds Jun. 14, 2011
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Mar. 22, 2011
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Aug. 10, 2010
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Jun. 29, 2010
-
Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Apr. 27, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of IRWD in WallStreetBets Daily Discussion
Recent insights relating to IRWD
Recent picks made for IRWD stock on CNBC
ETFs with the largest estimated holdings in IRWD
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IRWD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.